Cited by 202Neuroinflammation and Neurodegeneration MechanismsNeurological Disease Mechanisms and TreatmentsTryptophan and brain disorders

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Fractalkine‐induced activation of the phosphatidylinositol‐3 kinase pathway attentuates microglial activation in vivo and in vitro

Lyons, Anthony, Lynch, Aileen M., Downer, Eric J., Hanley, Riona, O’Sullivan, Joan B., Smith, Andrew, Lynch, Marina A.·2009·Journal of Neurochemistry

DOI 10.1111/j.1471-4159.2009.06253.x

Open this paper in CoChat — free account

Abstract

Several neurodegenerative disorders are associated with evidence of inflammation, one feature of which is increased activation of microglia, the most likely cellular source of inflammatory cytokines like interleukin‐1β. It is now recognized that interaction of microglia with other cells contributes to maintenance of microglia in a quiescent state and the complementary distribution of the chemokine, fractalkine (CX 3 CL1) on neurons and its receptor (CX 3 CR1) on microglia, suggests that this interaction may play a role in modulating microglial activation. Here we demonstrate that both soluble and membrane‐bound fractalkine attenuate lipopolysaccharide‐induced microglial activation in vitro. We also show that fractalkine expression is reduced in the brain of aged rats and this is accompanied by an age‐related increase in microglial activation. Treatment of aged rats with fractalkine attenuates the age‐related increase in microglial activation and the evidence indicates that fractalkine‐induced activation of the phosphatidylinositol‐3 kinase pathway is required to maintain microglia in a quiescent state both in vivo and in vitro.

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2009.06253.x

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Long-Term Potentiation and Memory
Lynch, M. A. (2004) · Physiological Reviews · doi:10.1152/physrev.00014.2003 · Cited by 2,075
Self-citation
A new class of membrane-bound chemokine with a CX3C motif
Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., & Schall, T. J. (1997) · Nature · doi:10.1038/385640a0 · Cited by 2,013
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557
Control of microglial neurotoxicity by the fractalkine receptor
Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531
Role for Neuronally Derived Fractalkine in Mediating Interactions between Neurons and CX3CR1-Expressing Microglia
Harrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176
Exaggerated neuroinflammation and sickness behavior in aged mice after activation of the peripheral innate immune system
Godbout, J. P., Chen, J., Abraham, J., Richwine, A. F., Berg, B. M., Kelley, K. W., & Johnson, R. W. (2005) · The FASEB Journal · doi:10.1096/fj.05-3776fje · Cited by 813
Microglial response to amyloid plaques in APPsw transgenic mice.
Frautschy, S. A., Yang, F., Irrizarry, M., Hyman, B. T., Saido, T. C., Hsiao, K., & Cole, G. M. (1998) · Europe PMC (PubMed Central) · Cited by 592
CD200 and membrane protein interactions in the control of myeloid cells
Barclay, A. N., Wright, G. J., Brooke, G. P., & Brown, M. H. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02223-8 · Cited by 422
Expression of CX 3 CR1 chemokine receptors on neurons and their role in neuronal survival
Meucci, O., Fatatis, A., Simen, A. A., & Miller, R. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090017497 · Cited by 385

Show all 46 references

Sorted by citations

Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Review: microglia of the aged brain: primed to be activated and resistant to regulation
Norden, D. M., & Godbout, J. P. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01306.x · Cited by 792
The Role of Glia in the Spinal Cord in Neuropathic and Inflammatory Pain
Old, E. A., Clark, A. K., & Malcangio, M. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-46450-2_8 · Cited by 662
Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity
Xanthos, D. N., & Sandkühler, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3617 · Cited by 580
Neuron–glia crosstalk in health and disease: fractalkine and CX 3 CR1 take centre stage
Sheridan, G. K., & Murphy, K. J. (2013) · Open Biology · doi:10.1098/rsob.130181 · Cited by 358
The multifaceted profile of activated microglia
Lynch, M. A. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8077-9 · Cited by 268
Self-citation
Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities
Hemonnot, A.-L., Hua, J., Ulmann, L., & Hirbec, H. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00233 · Cited by 298
Microglia in depression: current perspectives
Jia, X., Gao, Z., & Hu, H. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1815-6 · Cited by 288
The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
Pawelec, P., Ziemka‐Nałęcz, M., Sypecka, J., & Zalewska, T. (2020) · Cells · doi:10.3390/cells9102277 · Cited by 284
Microglia and aging: the role of the TREM2-DAP12 and CX3CL1-CX3CR1 axes
Mecca, C., Giambanco, I., Donato, R., & Arcuri, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010318 · Cited by 258
CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson’s disease
Pabon, M. M., Bachstetter, A. D., Hudson, C. E., Gemma, C., & Bickford, P. C. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-9 · Cited by 241
The Neuron-Astrocyte-Microglia Triad in Normal Brain Ageing and in a Model of Neuroinflammation in the Rat Hippocampus
Cerbai, F., Lana, D., Nosi, D., Petkova-Kirova, P., Zecchi, S., Brothers, H. M., Wenk, G. L., & Giovannini, M. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045250 · Cited by 251
Microglia: A new frontier for synaptic plasticity, learning and memory, and neurodegenerative disease research
Morris, G. P., Clark, I. A., Zinn, R., & Vissel, B. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.07.002 · Cited by 236
Mucosal Macrophages in Intestinal Homeostasis and Inflammation
Mowat, A. M., & Bain, C. C. (2011) · Journal of Innate Immunity · doi:10.1159/000329099 · Cited by 234
Age related changes in microglial phenotype vary between CNS regions: Grey versus white matter differences
Hart, A. D., Wyttenbach, A., Hugh Perry, V., & Teeling, J. L. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.11.006 · Cited by 230
Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge
Wynne, A. M., Henry, C. J., Huang, Y., Cleland, A., & Godbout, J. P. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.05.011 · Cited by 224
Microglial aging in the healthy CNS: phenotypes, drivers, and rejuvenation
Wong, W. T. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00022 · Cited by 239
Modulating neurotoxicity through CX3CL1/CX3CR1 signaling
Limatola, C., & Ransohoff, R. M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00229 · Cited by 210
Old Maids: Aging and Its Impact on Microglia Function
Koellhoffer, E. C., McCullough, L. D., & Ritzel, R. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040769 · Cited by 213
Microglia centered pathogenesis in ALS: insights in cell interconnectivity
Brites, D. M. T. O., & Vaz, A. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00117 · Cited by 213
Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide
Corona, A. W., Huang, Y., O’Connor, J. C., Dantzer, R., Kelley, K. W., Popovich, P. G., & Godbout, J. P. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-93 · Cited by 206
Lipopolysaccharide-induced interleukin (IL)-4 receptor-α expression and corresponding sensitivity to the M2 promoting effects of IL-4 are impaired in microglia of aged mice
Fenn, A. M., Henry, C. J., Huang, Y., Dugan, A., & Godbout, J. P. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.10.003 · Cited by 198
CX3CL1 Is Neuroprotective in Permanent Focal Cerebral Ischemia in Rodents
Cipriani, R., Villa, P., Chece, G., Lauro, C., Paladini, A., Micotti, E., Perego, C., De Simoni, M.-G., Fredholm, B. B., Eusebi, F., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3611-11.2011 · Cited by 166
Toll‐like receptor 4 contributes to poor outcome after intracerebral hemorrhage
Sansing, L. H., Harris, T. H., Welsh, F. A., Kasner, S. E., Hunter, C. A., & Karikó, K. (2011) · Annals of Neurology · doi:10.1002/ana.22528 · Cited by 182
Microglial Phenotype and Adaptation
Eggen, B. J. L., Raj, D. D. A., Hanisch, U., & Boddeke, H. W. G. M. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9490-4 · Cited by 187
Dysregulated neuronal–microglial cross-talk during aging, stress and inflammation
Jurgens, H. A., & Johnson, R. W. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2010.11.014 · Cited by 179
Age-related neuroinflammatory changes negatively impact on neuronal function
Lynch, M. A. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/neuro.24.006.2009 · Cited by 179
Self-citation
NLRP3 inflammasome activation in inflammaging
Latz, E., & Duewell, P. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.001 · Cited by 174
Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX3CR1)-deficient mice
Corona, A. W., Norden, D. M., Skendelas, J. P., Huang, Y., O’Connor, J. C., Lawson, M. A., Dantzer, R., Kelley, K. W., & Godbout, J. P. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.08.008 · Cited by 156
Dysregulated phosphoinositide 3-kinase signaling in microglia: shaping chronic neuroinflammation
Chu, E., Mychasiuk, R., Hibbs, M. L., & Semple, B. D. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02325-6 · Cited by 152
Fractalkine Attenuates Excito-neurotoxicity via Microglial Clearance of Damaged Neurons and Antioxidant Enzyme Heme Oxygenase-1 Expression
Noda, M., Doi, Y., Liang, J., Kawanokuchi, J., Sonobe, Y., Takeuchi, H., Mizuno, T., & Suzumura, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.169839 · Cited by 153
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Finneran, D. J., & Nash, K. R. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1412-9 · Cited by 132
Alzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy
Clayton, K. A., Enoo, A. A. V., & Ikezu, T. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00680 · Cited by 135
The Soluble Isoform of CX3CL1 Is Necessary for Neuroprotection in a Mouse Model of Parkinson's Disease
Morganti, J. M., Nash, K. R., Grimmig, B. A., Ranjit, S., Small, B. J., Bickford, P. C., & Gemma, C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0539-12.2012 · Cited by 141
Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression.
Noda, M., Doi, Y., Liang, J., Kawanokuchi, J., Sonobe, Y., Takeuchi, H., Mizuno, T., & Suzumura, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.a110.169839 · Cited by 132
Neurobiology of microglial action in CNS injuries: Receptor-mediated signaling mechanisms and functional roles
Hu, X., Liou, A. K. F., Leak, R. K., Xu, M., An, C., Suenaga, J., Shi, Y., Gao, Y., Zheng, P., & Chen, J. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.06.002 · Cited by 138
Targeting innate immunity for neurodegenerative disorders of the central nervous system
Andreasson, K. I., Bachstetter, A. D., Colonna, M., Ginhoux, F., Holmes, C., Lamb, B., Landreth, G., Lee, D. C., Low, D., Lynch, M. A., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13667 · Cited by 126
Self-citation
Fractalkine in the nervous system: neuroprotective or neurotoxic molecule?
Lauro, C., Catalano, M., Trettel, F., & Limatola, C. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12805 · Cited by 120
Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy
Nash, K. R., Lee, D. C., Hunt, J. B., Morganti, J. M., Selenica, M.-L., Moran, P., Reid, P., Brownlow, M., Guang-Yu Yang, C., Savalia, M., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.011 · Cited by 108
Long term adequate n-3 polyunsaturated fatty acid diet protects from depressive-like behavior but not from working memory disruption and brain cytokine expression in aged mice
Moranis, A., Delpech, J.-C., Smedt, V. D., Aubert, A., Guesnet, P., Lavialle, M., Joffre, C., & Layé, S. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.11.001 · Cited by 122
Fractalkine/CX3CL1 in Neoplastic Processes
Korbecki, J., Simińska, D., Kojder, K., Grochans, S., Gutowska, I., Chlubek, D., & Baranowska‐Bosiacka, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103723 · Cited by 110
Fractalkine Over Expression Suppresses α-Synuclein-mediated Neurodegeneration
Nash, K. R., Moran, P., Finneran, D. J., Hudson, C., Robinson, J., Morgan, D., & Bickford, P. C. (2014) · Molecular Therapy · doi:10.1038/mt.2014.175 · Cited by 107
CD200 fusion protein decreases microglial activation in the hippocampus of aged rats
Cox, F., Carney, D. G., Miller, A., & Lynch, M. A. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.10.004 · Cited by 107
Self-citation
High fat diet increases cognitive decline and neuroinflammation in a model of orexin loss
Duffy, C. M., Hofmeister, J. J., Nixon, J. P., & Butterick, T. A. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.11.008 · Cited by 112
Adenosine A1 Receptors and Microglial Cells Mediate CX3CL1-Induced Protection of Hippocampal Neurons Against Glu-Induced Death
Lauro, C., Cipriani, R., Catalano, M., Trettel, F., Chece, G., Brusadin, V., Antonilli, L., van Rooijen, N., Eusebi, F., Fredholm, B. B., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.26 · Cited by 105
Cx3cr1- deficient microglia exhibit a premature aging transcriptome
Gyoneva, S., Hosur, R., Gosselin, D., Zhang, B., Ouyang, Z., Cotleur, A. C., Peterson, M., Allaire, N., Challa, R., Cullen, P., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201900453 · Cited by 103
“It has been reported that CX3CL1 mRNA and protein expression decrease in the aged rodent brain (Lyons et al, 2009; Bachstetter et al, 2011), suggesting that reduced CX3CL1-CX3CR1 signaling may contribute to the transition of microglia to an aged phenotype.”
The impact of glial activation in the aging brain.
Lynch, A. M., Murphy, K. J., Deighan, B. F., O’Reilly, J.-A., Gun’ko, Y. K., Cowley, T. R., González-Reyes, R. E., & Lynch, M. A. (2010) · Europe PMC (PubMed Central) · Cited by 103
Self-citation
Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents
Poniatowski, Ł. A., Wojdasiewicz, P., Krawczyk, M., Szukiewicz, D., Gasik, R., Kubaszewski, Ł., & Kurkowska‐Jastrzębska, I. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9787-4 · Cited by 106
Alzheimer’s Disease: Mechanism and Approach to Cell Therapy
Amemori, T., Jendelová, P., Růžička, J., Urdzíková, L. M., & Syková, E. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125961 · Cited by 110
Microglia in the developing brain: from immunity to behaviour
Schlegelmilch, T., Henke, K., & Peri, F. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.08.004 · Cited by 108
Interaction of Tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation
Chidambaram, H., Das, R. R., & Chinnathambi, S. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00474-4 · Cited by 97
Increased micro-RNA 29b in the aged brain correlates with the reduction of insulin-like growth factor-1 and fractalkine ligand
Fenn, A. M., Smith, K. M., Lovett‐Racke, A. E., Guerau‐de‐Arellano, M., Whitacre, C. C., & Godbout, J. P. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.06.007 · Cited by 96
CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity
Sheridan, G. K., Wdowicz, A., Pickering, M., Watters, O., Halley, P., O’Sullivan, N. C., Mooney, C. M., O’Connell, D. J., Oâ€TMConnor, J. J., & Murphy, K. J. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00233 · Cited by 93
Environmental enrichment attenuates hippocampal neuroinflammation and improves cognitive function during influenza infection
Jurgens, H. A., & Johnson, R. W. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.05.015 · Cited by 95
Stress and aging act through common mechanisms to elicit neuroinflammatory priming
Fonken, L. K., Frank, M. G., Gaudet, A. D., & Maier, S. F. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.07.012 · Cited by 98
Microglial/macrophage GRK2 determines duration of peripheral IL-1β-induced hyperalgesia: Contribution of spinal cord CX3CR1, p38 and IL-1 signaling
Willemen, H. L. D. M., Eijkelkamp, N., Wang, H., Dantzer, R., Dorn, G. W., Kelley, K. W., Heijnen, C. J., & Kavelaars, A. (2010) · Pain · doi:10.1016/j.pain.2010.06.015 · Cited by 93
Activation of mixed glia by Aβ-specific Th1 and Th17 cells and its regulation by Th2 cells
McQuillan, K., Lynch, M. A., & Mills, K. H. G. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.01.003 · Cited by 90
Self-citation
Effects of Microglial Activation and Polarization on Brain Injury After Stroke
Dong, R., Huang, R., Wang, J., Liu, H., & Xu, Z. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.620948 · Cited by 87
Rod-shaped microglia morphology is associated with aging in 2 human autopsy series
Bachstetter, A. D., Ighodaro, E. T., Hassoun, Y., Aldeiri, D., Neltner, J. H., Patel, E., Abner, E. L., & Nelson, P. T. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.12.028 · Cited by 89
Cognitive and Behavioral Consequences of Impaired Immunoregulation in Aging
Corona, A. W., Fenn, A. M., & Godbout, J. P. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9313-4 · Cited by 87
The Potential Role of Dysfunctions in Neuron-Microglia Communication in the Pathogenesis of Brain Disorders
Chamera, K., Trojan, E., Szuster-Głuszczak, M., & Basta‐Kaim, A. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191113101629 · Cited by 82
Tumor Immune Microenvironment and Immunotherapy in Brain Metastasis From Non-Small Cell Lung Cancer
Wang, Y.-C., Chen, R., Wa, Y., Ding, S., Yang, Y., Liao, J., Tong, L., & Xiao, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.829451 · Cited by 78
Rod microglia and their role in neurological diseases
Holloway, O. G., Canty, A. J., King, A. E., & Ziebell, J. M. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.02.005 · Cited by 71
The neuroinflammatory role of microglia in Alzheimer's disease and their associated therapeutic targets
AmeliMojarad, M., & AmeliMojarad, M. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14856 · Cited by 73
The Emerging Role of the Interplay Among Astrocytes, Microglia, and Neurons in the Hippocampus in Health and Disease
Lana, D., Ugolini, F., Nosi, D., Wenk, G. L., & Giovannini, M. G. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.651973 · Cited by 73
Dynamic changes of CX3CL1/CX3CR1 axis during microglial activation and motor neuron loss in the spinal cord of ALS mouse model
Zhang, J., Liu, Y., Liu, X., Li, S., Cheng, C., Chen, S., & Le, W. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0138-4 · Cited by 57
The effects of human immunoglobulin G on enhancing tissue protection and neurobehavioral recovery after traumatic cervical spinal cord injury are mediated through the neurovascular unit
Chio, J. C. T., Wang, J., Badner, A., Hong, J., Surendran, V., & Fehlings, M. G. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1518-0 · Cited by 71
CX3CL1/CX3CR1 in Alzheimer’s Disease: A Target for Neuroprotection
Chen, P., Zhao, W., Guo, Y., Xu, J., & Yin, M. (2016) · BioMed Research International · doi:10.1155/2016/8090918 · Cited by 67
Fractalkine (CX3CL1) signaling and neuroinflammation in Parkinson’s disease: Potential clinical and therapeutic implications
Angelopoulou, E., Paudel, Y. N., Shaikh, M. F., & Piperi, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104930 · Cited by 65
Neuron-Microglia Dialogue and Hippocampal Neurogenesis in the Aged Brain.
Gemma, C., Bachstetter, A. D., & Bickford, P. C. (2010) · Europe PMC (PubMed Central) · Cited by 62
Suppressed pro-inflammatory response of microglia in CX3CR1 knockout mice
Mattison, H. A., Nie, H., Gao, H., Zhou, H., Hong, J., & Zhang, J. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.02.008 · Cited by 66
Age-related changes in the hippocampus (loss of synaptophysin and glial–synaptic interaction) are modified by systemic treatment with an NCAM-derived peptide, FGL
Ojo, B., Rezaie, P., Gabbott, P. L. A., Davies, H. A., Colyer, F. M., Cowley, T. R., Lynch, M. A., & Stewart, M. G. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.09.013 · Cited by 61
Self-citation
The impact of neuroimmune changes on development of amyloid pathology; relevance to A lzheimer's disease
Lynch, M. A. (2013) · Immunology · doi:10.1111/imm.12156 · Cited by 64
Self-citation
The Role of Microglia in Prion Diseases: A Paradigm of Functional Diversity
Obst, J., Simon, E., Mancuso, R., & Gómez‐Nicola, D. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00207 · Cited by 61
Regulation of CNS precursor function by neuronal chemokines
Watson, A. E. S., Goodkey, K., Footz, T. K., & Voronova, A. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134533 · Cited by 57
Microglial Priming in Infections and Its Risk to Neurodegenerative Diseases
Lima, M. N., Barbosa‐Silva, M. C., & Maron‐Gutierrez, T. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.878987 · Cited by 62
CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis
Szukiewicz, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094679 · Cited by 59
Antibiotic-induced gut dysbiosis leads to activation of microglia and impairment of cholinergic gamma oscillations in the hippocampus
Çalışkan, G., French, T., Lacalle, S. E., del Ángel, M., Steffen, J., Heimesaat, M. M., Dunay, I. R., & Stork, O. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.10.007 · Cited by 57
Higher Plasma Fractalkine Is Associated With Better 6-Month Outcome From Ischemic Stroke
Donohue, M. M., Cain, K., Zierath, D., Shibata, D., Tanzi, P. M., & Becker, K. J. (2012) · Stroke · doi:10.1161/strokeaha.112.657411 · Cited by 53
Progesterone Attenuates Microglial-Driven Retinal Degeneration and Stimulates Protective Fractalkine-CX3CR1 Signaling
Roche, S. L., Wyse‐Jackson, A. C., Gómez‐Vicente, V., Lax, P., Ruiz‐Lopez, A. M., Byrne, A. M., Cuenca, N., & Cotter, T. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165197 · Cited by 55
The Modulatory Properties of Chronic Antidepressant Drugs Treatment on the Brain Chemokine – Chemokine Receptor Network: A Molecular Study in an Animal Model of Depression
Trojan, E., Ślusarczyk, J., Chamera, K., Kotarska, K., Głombik, K., Kubera, M., & Basta‐Kaim, A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00779 · Cited by 54
Enhancing fractalkine/CX3CR1 signalling pathway can reduce neuroinflammation by attenuating microglia activation in experimental diabetic retinopathy
Jiang, M., Xie, H., Zhang, C., Wang, T., Tian, H., Lü, L., Xu, J., Xu, G., Liu, L., & Zhang, J. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17179 · Cited by 51
The Implications of Microglial Regulation in Neuroplasticity-Dependent Stroke Recovery
Qiao, C., Liu, Z., & Qie, S. (2023) · Biomolecules · doi:10.3390/biom13030571 · Cited by 55
Fractalkine/CX3CR1-Dependent Modulation of Synaptic and Network Plasticity in Health and Disease
Camacho-Hernández, N. P., & Peña‐Ortega, F. (2023) · Neural Plasticity · doi:10.1155/2023/4637073 · Cited by 52
Involvement of CX3CL1/CX3CR1 in depression and cognitive impairment induced by chronic unpredictable stress and relevant underlying mechanism
Liu, Y., Zhang, T., Meng, D., Sun, L., Yang, G., He, Y., & Zhang, C. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112371 · Cited by 51
Differential Modulation of TREM2 Protein during Postnatal Brain Development in Mice
Chertoff, M., Shrivastava, K., González, B., Acarín, L., & Giménez‐Llort, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072083 · Cited by 46
Fractalkine-CX3CR1 signaling is critical for progesterone-mediated neuroprotection in the retina
Roche, S. L., Wyse‐Jackson, A. C., Ruiz‐Lopez, A. M., Byrne, A. M., & Cotter, T. G. (2017) · Scientific Reports · doi:10.1038/srep43067 · Cited by 46
Single episode of mild murine malaria induces neuroinflammation, alters microglial profile, impairs adult neurogenesis, and causes deficits in social and anxiety-like behavior
Guha, S. K., Tillu, R., Sood, A., Patgaonkar, M. S., Nanavaty, I. N., Sengupta, A., Sharma, S., Vaidya, V. A., & Pathak, S. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.009 · Cited by 45
Brain region-specific microglial and astrocytic activation in response to systemic lipopolysaccharides exposure
Brandi, E., Torres-Garcia, L., Svanbergsson, A., Haikal, C., Liu, D., Li, W., & Li, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.910988 · Cited by 47
Different actions of endothelin-1 on chemokine production in rat cultured astrocytes: reduction of CX3CL1/fractalkine and an increase in CCL2/MCP-1 and CXCL1/CINC-1
Kōyama, Y., Kotani, M., Sawamura, T., Kuribayashi, M., Konishi, R., & Michinaga, S. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-51 · Cited by 44
Advances in immunotherapy for the treatment of spinal cord injury
Mamun, A. A., Monalisa, I., Kubra, K. T., Akter, A., Akter, J., Sarker, T., Munir, F., Wu, Y., Jia, C., Taniya, M. A., et al. (2020) · Immunobiology · doi:10.1016/j.imbio.2020.152033 · Cited by 40
Beneficial impact of intracerebroventricular fractalkine administration on behavioral and biochemical changes induced by prenatal stress in adult rats: Possible role of NLRP3 inflammasome pathway
Ślusarczyk, J., Trojan, E., Wydra, K., Głombik, K., Chamera, K., Kucharczyk, M. W., Budziszewska, B., Kubera, M., Lasoń, W., Filip, M., et al. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.05.008 · Cited by 41
Fractalkine Induces Hepcidin Expression of BV-2 Microglia and Causes Iron Accumulation in SH-SY5Y Cells
Pandur, E., Tamási, K., Pap, R., Varga, E., Miseta, A., & Sipos, K. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00694-4 · Cited by 37
Microglia: A pharmacological target for the treatment of age-related cognitive decline and Alzheimer’s disease
McKee, C., Hoffos, M., Vecchiarelli, H. A., & Tremblay, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1125982 · Cited by 38
Modulation of Neuroimmune Responses on Glia in the Central Nervous System: Implication in Therapeutic Intervention Against Neuroinflammation
Chang, R. C., Chiu, K., Ho, J. Y. S., & So, K. (2009) · Cellular and Molecular Immunology · doi:10.1038/cmi.2009.42 · Cited by 38
A Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders
lusarczyk, J., Trojan, E., Chwastek, J., Głombik, K., & Basta‐Kaim, A. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160219131357 · Cited by 37
Alterations in the Interplay between Neurons, Astrocytes and Microglia in the Rat Dentate Gyrus in Experimental Models of Neurodegeneration
Lana, D., Ugolini, F., Nosi, D., Wenk, G. L., & Giovannini, M. G. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00296 · Cited by 39
Fractalkine enhances oligodendrocyte regeneration and remyelination in a demyelination mouse model
de Almeida, M. M. A., Watson, A. E. S., Bibi, S., Dittmann, N. L., Goodkey, K., Sharafodinzadeh, P., Galleguillos, D., Nakhaei‐Nejad, M., Kosaraju, J., Steinberg, N., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.12.001 · Cited by 36
CNS-Wide over Expression of Fractalkine Improves Cognitive Functioning in a Tauopathy Model
Finneran, D. J., Morgan, D., Gordon, M. N., & Nash, K. R. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9822-5 · Cited by 34
Dysfunctional microglia and tau pathology in Alzheimer’s disease
Ayyubova, G. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0087 · Cited by 35

Authors: Lyons, A., Lynch, A. M., Downer, E. J., Hanley, R., O’Sullivan, J. B., Smith, A., & Lynch, M. A.
Affiliations: Trinity College Dublin (IE)
Corresponding author: Lynch, Marina A.
ORCID: Lynch, Aileen M.
Downer, Eric J.
Lynch, Marina A.
Venue: Journal of Neurochemistry
Publisher: Wiley
Published: 2009-08-10
Volume: 110
Issue: 5
Pages: 1547-1556
ISSN: 0022-3042 (ISSN-L)
1471-4159
DOI: 10.1111/j.1471-4159.2009.06253.x
OpenAlex: W2036586619
Cited by: 202
References: 46
Citations by year: 2026: 8 · 2025: 8 · 2024: 16 · 2023: 9 · 2022: 15 · 2021: 12 · 2020: 12 · 2019: 16 · 2018: 11 · 2017: 13 · 2016: 12 · 2015: 5 · 2014: 10 · 2013: 16 · 2012: 11
FWCI: 8.31
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Journal of Neurochemistry (publishedVersion)
PubMed (publishedVersion)
Funders: Science Foundation Ireland
Topics: Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords: fractalkine, CX3CR1, microglial activation, phosphatidylinositol 3-kinase pathway, neuroinflammation, lipopolysaccharide, aging, neurodegenerative diseases, IL-1β, microglia-neuron interaction
MeSH terms: Age Factors, Aging, Animals, Animals, Newborn, Cells, Cultured, Enzyme Activation, Lipopolysaccharides, Male, Membrane Proteins, Solubility, Signal Transduction, Rats, Wistar, Microglia, Phosphatidylinositol 3-Kinases, Rats, Chemokine CX3CL1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Fractalkine‐induced activation of the phosphatidylinositol‐3 kinase pathway attentuates microglial activation in vivo and in vitro

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks